On Tuesday, February 4, Dr. Agarwal’s Health Care shares had a quiet start on the NSE, trading at ₹402, also the IPO price. In the meantime, the stock was down 1.27 percent from the issue price, trading at ₹396.90 on the BSE.
Dr. Agarwal’s Health Care IPO listing:
On Tuesday, February 4, Dr. Agarwal’s Health Care shares had a quiet start on the NSE, trading at ₹402, also the price of the initial public offering (IPO). In the meantime, the stock was down 1.27 percent from the issue price, trading at ₹396.90 on the BSE.
The ₹3,027.26 crore IPO of Dr. Agarwal’s Health Care was available for subscription between January 29 and January 31. The price range for each equity share during the IPO was set at ₹382-402.
Dr. Agarwal’s Health Care IPO ended with high demand after three days of bidding, receiving 1.49 times the offers. Out of the 5.35 crore shares available, 7.98 crore were bid on during the IPO. With only 0.42 times bids, the retail investor sector did not fare well. The three-day initial public offering (IPO) period ended with 0.39 times bids because the non-institutional investors (NII) category was not fully subscribed at the same time. Meanwhile, 4.41 bids were placed on the Qualified Institutional purchaser’s quota. Subscriptions for the employee and other quotas were 0.26 and 0.51 times, respectively, indicating that they were not entirely bid.
About the IPO:
The new issuance of 0.75 crore shares, totaling ₹300 crore, and the sale of 6.78 crore shares, totaling ₹2,727.26 crore, comprised Dr. Agarwal’s Health Care IPO. With a minimum size of 35 shares and a minimum investment of ₹14,070, retail investors were eligible to apply.
Before its first public offering (IPO) on January 28, 2024, Dr. Agarwals Healthcare raised ₹875.51 crore from anchor investors.
The net proceeds from the issuance will be used by the firm for several purposes, including the partial or complete repayment of some loans. The money will also be used for general business needs and possible unspecified inorganic acquisitions.
The book-running lead managers of the Dr. Agarwals Healthcare IPO are Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited, and Kotak Mahindra Capital Company Limited. The issue’s registrar is Kfin Technologies Limited.
Since its founding in 2010, Dr. Agarwal’s Health Care Limited has offered a comprehensive range of eye care services, such as cataract and refractive surgeries, consultations, diagnostics, non-surgical treatments, and the retail of eye care-related optical products, contact lenses, accessories, and medications.
The organization employed 737 doctors to serve patients throughout its sites as of September 30, 2024. It treated 2.13 million patients and carried out 220,523 procedures throughout this time. The business performed 140,787 procedures and serviced 1.15 million patients in the fiscal year’s first half, which ended on September 30, 2024.
